:format(webp))
Maximum safety for product and operator
Containment
Our containment portfolio includes oRABS, cRABS and isolators. These represent physical barriers that reliably protect aseptic processes in pharmaceutical production from contamination.
Containment systems are essential key technologies for modern pharmaceutical production. They create controlled, closed environments in which sensitive processes can be carried out safely and reproducibly. The central solutions include oRABS (Open Restricted Access Barrier Systems), cRABS (Closed Restricted Access Barrier Systems) and isolators. While oRABS enable controlled access under defined conditions, cRABS and isolators in particular offer an even greater degree of separation between people and products – for maximum product safety and minimised risk of contamination.
As a total solution provider, we develop integrated containment systems that are perfectly customised to your processes. Our focus is on safe aseptic filling, where the highest quality and safety standards must be met. In doing so, we consistently take into account the current regulatory requirements, in particular the specifications of Annex 1 of the EU GMP guidelines.
From the initial concept phase through engineering and qualification to service and modernisation, we support you throughout the entire life cycle of your system. In this way, we ensure that your production remains efficient, compliant and reliable not only today, but also in the future.
Our portfolio
Our isolator technology and barrier systems
Discover our portfolio of isolator technology and barrier systems - developed for the highest standards of safety, efficiency and compliance. From flexible oRABS and cRABS solutions to high-performance isolators, we offer customised systems for every application in aseptic production.
:format(webp))
:format(webp))

:format(webp))